Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 3/20 | 0.53 |
| ▸ | NAAA | Q02083 | 2/20 | 0.44 |
| ▸ | HTT | P42858 | 2/20 | 0.43 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL873000 | 1.00 | EPHX1 (0.53) | EPHX1NAAAHTTCYP19A1CA12 | |
| SCHEMBL11591329 | 1.00 | EPHX1 (0.53) | EPHX1NAAAHTTCYP19A1CA12 | |
| SCHEMBL10598881 | 1.00 | EPHX1 (0.53) | EPHX1NAAAHTTCYP19A1CA12 | |
| SCHEMBL11589164 | 1.00 | EPHX1 (0.53) | EPHX1NAAAHTTCYP19A1CA12 | |
| SCHEMBL8582705 | 1.00 | EPHX1 (0.53) | EPHX1NAAAHTTCYP19A1CA12 | |
| SCHEMBL11593674 | 1.00 | EPHX1 (0.53) | EPHX1NAAAHTTCYP19A1CA12 | |
| SCHEMBL1081048 | 0.98 | EPHX1 (0.52) | EPHX1NAAAHTTCYP19A1CA12 | |
| SCHEMBL305953 | 0.98 | EPHX1 (0.50) | EPHX1NAAAHTTCYP19A1CA12 | |
| SCHEMBL698655 | 0.93 | — | — | |
| SCHEMBL10344338 | 0.93 | EPHX1 (0.45) | EPHX1NAAAHTTCYP19A1CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 726 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110957533-B | Low-temperature electrolyte for lithium ion battery | 永州市华米新能源科技有限公司 | 2025-01-24 | — | — | CN | claimed |
| CN-115856171-A | Method for simultaneously detecting multiple fat-soluble vitamins and multiple steroid hormones | 湖南华务星辰医学检验实验室有限公司 | 2023-03-28 | — | — | CN | claimed |
| CN-110957533-A | Low-temperature electrolyte for lithium ion battery | 深圳市东聚能源科技有限公司 | 2020-04-03 | — | — | CN | claimed |
| CN-107417641-A | Benzothiadiazine analog derivative and preparation method and application | 山东大学 | 2017-12-01 | — | — | CN | claimed |
| EP-2793887-B1 | SULPHONYLAMINOPYRROLIDINONE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC APPLICATION | SANOFI SA (FR) | 2015-10-21 | — | — | EP | claimed |
| US-9150544-B2 | Sulphonylaminopyrrolidinone derivatives, their preparation and their therapeutic application | SANOFI (FR) | 2015-10-06 | — | — | US | claimed |
| US-20140329801-A1 | SULPHONYLAMINOPYRROLIDINONE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION | SANOFI (FR) | 2014-11-06 | — | — | US | claimed |
| EP-2793887-A1 | SULPHONYLAMINOPYRROLIDINONE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION | SANOFI (FR) | 2014-10-29 | — | — | EP | claimed |
| EP-2189443-B1 | TRICYCLIC AMIDE COMPOUND | RES FOUND ITSUU LAB (JP) | 2013-10-23 | — | — | EP | claimed |
| WO-2013092756-A1 | SULPHONYLAMINOPYRROLIDINONE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION | SANOFI (FR) | 2013-06-27 | — | — | WO | claimed |
| WO-1995011905-A1 | 2-(PYRAZOL-3-YL)CARBAPENEM DERIVATIVES | SMITHKLINE BEECHAM PLC (GB) | 1995-05-04 | — | — | WO | claimed |
| EP-0639193-A1 | ESTERS OF ANTIBACTERIAL CONDENSED CARBAPENEME DERIVATIVES | GLAXO S.p.A. (IT) | 1995-02-22 | — | — | EP | claimed |
| EP-0603001-A1 | Biphenyl derivatives, their preparation and their use for the treatment of hypertension and cardiac disease | SANKYO COMPANY LIMITED (JP) | 1994-06-22 | — | — | EP | claimed |
| EP-0495953-B1 | 10-(1-Hydroxyethyl)-11-oxo-1-azatricyclo[7.2.0.0(3,8)]undec-2-ene-2-carboxylic acid esters and a process for preparing thereof | GLAXO SPA (IT) | 1994-06-08 | — | — | EP | claimed |
| EP-0557167-A1 | Preparation of fluorinated functional compounds | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1993-08-25 | — | — | EP | claimed |
| WO-1992015588-A1 | ESTERS OF ANTIBACTERIAL CONDENSED CARBAPENEME DERIVATIVES | GLAXO S.P.A. (IT) | 1992-09-17 | — | — | WO | claimed |
| EP-0502465-A1 | Esters of antibacterial condensed carbapenemederivatives | GLAXO S.p.A. (IT) | 1992-09-09 | — | — | EP | claimed |
| EP-0495953-A1 | 10-(1-Hydoxyethyl)-11-oxo-1-azatricyclo(7.2.0.0(3,8)undec-2-ene-2-carboxylic acid esters and a process for preparing thereof. | GLAXO SPA (IT) | 1992-07-29 | — | — | EP | claimed |
| WO-1992003437-A1 | 10(1-HYDROXYETHYL)-11-OXO-1-AZATRICYCLO[7.2.0.0.3.8]UNDEC-2-ENE-2-CARBOXYLIC ACID ESTERS AND A PROCESS FOR PREPARING THEREOF | GLAXO S.P.A. (IT) | 1992-03-05 | — | — | WO | claimed |
| EP-0128029-B1 | CEPHALOSPORIN ESTER DERIVATIVES, THEIR PRODUCTION AND USE | Takeda Chemical Industries, Ltd. (JP) | 1989-02-08 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140329801-A1 | SULPHONYLAMINOPYRROLIDINONE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION | F9, TFPI, SERPINC1 | EPHX1 1946/4885NAAA 525/4885HTT 2347/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.